Investigation of the negative inotropic effects of 17β-oestradiol in human isolated myocardial tissues

British Journal of Pharmacology

Volumn 119, Issue 1, 1996, Pages 43-48

  Sitzler, Gerhard ^a   Lenz, Olaf ^a   Kilter, Heiko ^a   La Rosee, Karl ^a   Böhm, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

17 oestradiol; Calcium antagonism; Cardiac muscle; Contractility

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 1,4 DIHYDROPYRIDINE RECEPTOR; CALCIUM CHANNEL STIMULATING AGENT; ESTRADIOL; PROGESTERONE; TESTOSTERONE; TRITIUM;

ARTICLE; CALCIUM ANTAGONISM; CONTROLLED STUDY; FEMALE; HEART ATRIUM; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE; HEART PAPILLARY MUSCLE; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; PRIORITY JOURNAL; RADIOASSAY; RECEPTOR BINDING;

EID: 0029789672     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15675.x     Document Type: Article

References (35)

1. + + channels. Nature, 311, 570-572.
2. COLLINS, P., ROSANO, G.M.C., JIANG, C., LINDSAY, D.C., SARREL, P.M. & POOLE-WILSON, P.A. (1993). Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet, 341, 1264-1265.
3. DUBE, G.P., BAIK, Y.H. & SCHWARTZ, A. (1985). Effects of a novel calcium channel agonist dihydropyridine analogue, Bay K 8644, on pig coronary artery: Biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. J. Cardiovasc. Pharmacol., 7, 377-389.
4. ELLIOT, R.A., CASTLEDEN, C.M., MIODRAG, A. & KIRWAN, P. (1992). The direct effects of diethylstilboestrol and nifedipine on the contractile responses of isolated human and rat detrusor muscles. Eur. J. Clin. Pharmacol., 43, 149-155.
5. FABIATO, A. (1989). Appraisal of the physiological relevance of two hypotheses for the mechanism of calcium release from the mammalian cardiac sarcoplasmic reticulum: calcium-induced release versus charge-coupled release. Mol. Cell. Biochem., 89, 135-140.
6. FARHAT, M., ABI-YOUNES, S., VARGAS, R., WOLFE, M.R., CLARKE, R. & RAMWELL, P.W. (1992). Vascular non-genomic effects of estrogen. In Sex Steroids and Cardiovascular System. ed. Ramwell, P.W., Rubanyi, G. & Schillinger, E. pp. 145-159. Berlin: Springer-Verlag.
7. m cyclic AMP phosphodiesterases in cardiac cells. Mol. Pharmacol., 38, 426-433.
8. GASPARD, U.J., GOTTAL, J.M. & VAN DEN BRULE, F.A. (1995). Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas, 21, 171-178.
9. + + channel agonist Bay K 8644. J. Pharmacol. Exp. Ther., 231, 8-15.
10. 2+ in guinea-pig isolated cardiac myocytes. Br. J. Pharmacol., 106, 739-745.
11. JIANG, C., SARREL, P.M.P., P.A., LINDSAY, D.C., POOLE-WILSON, P.A. & COLLINS, P. (1991). Endothelium-independent relaxation of rabbit coronary artery by 17b-oestradiol in vitro. Br. J. Pharmacol., 104, 1033-1037.
12. JIANG, C., SARREL, P.M., POOLE-WILSON, P.A. & COLLINS, P. (1992b). Acute effect of 17b-oestradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol., 263, H271-H275.
13. KARAS, R.H., PATTERSON, B.L. & MENDELSOHN, M.E. (1994). Human vascular smooth muscle cells contain functional estrogen receptor. Circulation, 89, 1943-1950.
14. KUSHAWAHA, R.S. (1992). Female sex steroid hormones and lipoprotein metabolism. Curr. Opin. Lipidol., 3, 167-172.
15. LOHMANN, S.M., FISCHMEISTER, R. & WALTER, U. (1995). Signal transduction by cyclic GMP in the heart. Basic Res. Cardiol., 86, 503-514.
16. LONGO, L.D. (1989). Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am. J. Physiol., 245, R720-R729.
17. LOWRY, O.H., ROSEBROUGH, N.Y., FARR, A.F. & RANDALL, R.J. (1951). Protein measurement with the folin phenol regent. J. Biol. Chem., 193, 265-275.
18. LUOTOLA, H. (1983). Blood pressure and hemodynamics in postmenopausal women during estradiol-17b substitution. Ann. Clin. Res., 15, 1-121.
19. MAGNESS, R.B. & ROSENFELD, C.R. (1989). Local and systemic estradiol-17b: effects of uterine and systemic vasodilation. Am. J. Physiol., 256, E536-E542.
20. MUCK, A.O., SEEGER, H., KORTE, K. & LIPPERT, T.H. (1994). Effect of estradiol on calcium-influx in human umbilical cord endothelial cells. Med. Sci. Res., 22, 19
21. MÜGGE, A., RIEDEL, M., BARTON, M., KUHN, M. & LICHTLEN, P.R. (1993). Endothelium-independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc. Res., 27, 1939-1942.
22. NABULSKI, A.A., FOLSOM, A.R., WHITE, A., PATSCH, W., HEISS, G., WU, K.K. & SZKLO, M. (1993). Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New Engl. J. Med., 328, 1069-1075.
23. 2+ currents in aortic smooth muscle cells. Eur. J. Pharmacol., 294, 625-635.
24. RADDINO, R., MANCA, C., POLL, E., BOLOGNESI, R. & VISIOLI, E (1986). Effects of 17β-estradiol on the isolated rabbit heart. Arch. Int. Pharmacodyn. Ther., 281, 57-65.
25. SCATCHARD, G. (1949). The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci., 51, 660-672.
26. 2+ channel in human myocardium. Anesthesiology, 79, 332-339.
27. SCHUMACHER, M. (1990). Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci., 13, 359-362.
28. SCHWARTZ, A., GRUPP, I.L., GRUPP, G., WILLIAMS, J.S. & VAGHY, P.L. (1984). Effects of dihydropyridine calcium channel modulators in the heart: pharmacological and radioligand binding correlations. Biochem. Biophys. Res. Commun., 125, 387-394.
29. SHELDON, J.H. & ARGENTIERI, T.M. (1995). Acute administration of 17β-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes. J. Pharmacol. Exp. Ther., 274, 723-729.
30. SLATER, A.J., GUDE, N., CLARKE, I.J. & WALTERS, W.A.W. (1986). Haemodynamic changes and left ventricular performance during high-dose oestrogen administration to male transsexuals. Br. J. Obstetrics Gynaecol., 93, 532-538.
31. STAMPFER, M.J., COLDITZ, G.A., WILLET, W.C., MANSON, J.E., ROSNER, B. & SPEIZER, F.E. (1991). Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. N. Engl. J. Med., 325, 756 762.
32. 2+ uptake of uterine smooth muscle cells through potential-sensitive channels. Biol. Reprod., 37, 361-368.
33. SZEGO, C.M. & DAVIS, J.S. (1967). Adenosine 3, 5-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A., 58, 1711-1718.
34. VOLTERRANI, M., ROSANO, G.M.C., COATS, A., BEALE, C. & COLLINS, P. (1995). Estrogen acutely increases peripheral blood flow in postmenopausal women. Am. J. Med., 99, 119-122.
35. WILLIAMS, J.K., ADAMS, D.M., HERRINGTON, D.M. & CLARKSON, T.B. (1992). Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol., 20, 452-457.